Troy von Beck

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Hematopoietic Stem Cell

Acute Myeloid Leukemia

Replacement Therapy

Top Venues

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Kelly von Beck, Troy von Beck, P Brent Ferrell, Alexander G Bick, Ashwin Kishtagari
Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment. Blood cancer journal 13 (1) (2023)
Kelly von Beck, Troy von Beck, P Brent Ferrell, Alexander G Bick, Ashwin Kishtagari
Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment. Blood cancer journal 13 (1) (2023)
Kelly von Beck, Troy von Beck, P Brent Ferrell, Alexander G Bick, Ashwin Kishtagari
Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment. Blood cancer journal 13 (1) (2023)
Kelly von Beck, Troy von Beck, P Brent Ferrell, Alexander G Bick, Ashwin Kishtagari
Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment. Blood cancer journal 13 (1) (2023)
Troy von Beck, Luis Mena Hernandez, Hongyi Zhou, Katharine A Floyd, Mehul S Suthar, Jeffrey Skolnick, Joshy Jacob
Atovaquone and Pibrentasvir Inhibit the SARS-CoV-2 Endoribonuclease and Restrict Infection In Vitro but Not In Vivo. Viruses 15 (9) (2023)